REBIRTH Research Group Gruh
The RG Myocardial Tissue Engineering aims at the establishment and characterization of bio-artificial cardiac tissues (BCTs) for future therapeutic applications. Currently, cardiac cells derived from the different stem cell types are analyzed for their potential to form functional cardiac tissues in combination with collagen based matrices. Functionality of these tissues is tested in a custom made bioreactor system, with a focus on contractility (frequency and force) and viability of the tissue.
More informationen about the RG Myocardial Tissue Engineering can be found here.